Skip to main content
Equibles
RMSL logo

RMSL · RemSleep Holdings Inc.

Track RMSL — free

Use RMSL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RMSL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 +0.00 (+7.14%) At close · Oct 19
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As of June 30, 2026, there is substantial doubt regarding our ability to continue as a going concern as we have not generated sufficient cash flow from revenue to fund our proposed business.”
View the 10-Q filed Aug 14, 2026
Market Cap
$2.38M
Shares
1.74B
Volume · Oct 19 143.74K Avg daily vol (3M) 4.74M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.00 Day$0.00–0.00 52W close$0.00–0.01 Avg vol 30d1.5M Short int10K · 0.0% float · 1.0d Short vol96% DataJan 2020–Oct 2026 Filing10-Q · Aug 14

Up next

Latest filing: 10-Q
filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$11,897
Trailing 12 months
Net income (TTM)
−$3.04M
Trailing 12 months
Revenue growth YoY
-80.0%
Year over year
Operating margin
-23,296.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+10.8%
Year over year · more shares
Price change (1Y)
-62.2%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▼62.2% $51,947 −$270,433 '23 Q3 · $7,456 −$1.06M '23 Q4* ▼32.4% $57,881 −$252,580 '24 Q1 ▼53% $27,594 −$225,599 '24 Q2 ▼28.3% $37,260 −$277,909 '24 Q3 ▼174.4% −$5,550 −$321,909 '24 Q4* ▼82.5% $4,824 −$287,772 '25 Q2 LATEST ▼80% $7,454 −$2.31M '25 Q3

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −61%
below
Price vs 50-day avg −6%
below
RSI (14) 48
neutral
MACD trend Negative
52-week position 4%
near low
Momentum
relative strength
Very Weak
1-month return −6%
trailing
6-month return −70%
trailing
YTD return −12%
this year
Relative strength −78%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Accumulating
+1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · ▲ +333333.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 5-yr low, contrarian setup
Squeeze score 40
low risk · 0–100
Fundamentals
Weak
Revenue growth −86%
Y/Y
Gross margin 24%
expanding
Free cash flow $-627.5K
Balance sheet $362.4K
net debt
Quant / Vol
risk profile
Very High
Volatility 321%
annualized · 1-yr
Max drawdown −85%
past year
ATR 20.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−61% Bearish
Price vs 50-day avg
−6% Bearish
RSI (14)
48 Neutral
MACD trend
Negative Bearish
52-week position
4% Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Accumulating
+1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · ▲ +333333.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 5-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 4% Range high $0
vs 200-day avg -61% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RMSL
RemSleep Holdings Inc.
this stock
$2.38M -11.8% -85.7% — 0.0%
ABT
Abbott Laboratories
 $179.20B -18.2% +5.7% 33.3 0.8%
MDT
Medtronic plc
 $118.67B -1.5% +8.4% 22.9 3.1%
SYK
Stryker Corp
 $114.28B -13.4% +11.2% 30.9 1.5%
BSX
Boston Scientific Corp
 $66.02B -52.2% +12.5% 18.4 2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1
% held
0.0%
Net QoQ
+200.0K sh
Top holder
NORTH STAR ASSET MANAGEME…
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
10.0K
Days to cover
1.0d
Change
+10.0K sh
View
Short Volume
Short vol %
96%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
8
Value
$0
As of
Apr 30, 2026
View
Off-Exchange
Off-exchange %
99.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$16.7K
Net income (FY)
$-3.0M
EPS diluted
$0.00
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 28, 2026
This year
6
View

Performance

5D 20D 120D MTD YTD
RMSL +7.1% -6.3% -70.0% +0.0% -11.8%
SPY -1.5% -0.9% +7.7% +0.5% +12.4%
vs SPY +8.6% -5.3% -77.7% -0.5% -24.2%
Key facts CIK 1412126 CUSIP 75990A200 Visit website